An increasing number of G protein-coupled receptors (GPCRs) have been reported to be expressed in the plasma membrane as dimers. Since most ligand binding data are currently fitted by classical equations developed only for monomeric receptors, the interpretation of data could be misleading in the presence of GPCR dimers. On the other hand, the equations developed from dimer receptor models assuming the existence of two orthosteric binding sites within the dimeric molecule offer the possibility to directly calculate macroscopic equilibrium dissociation constants for the two sites, an index of cooperativity (D C ) that reflects the molecular communication within the dimer and, importantly, a constant of radioligand-competitor allosteric interaction (K DAB ) in competitive assays. Here, we provide a practical way to fit competitive binding data that allows the interpretation of apparently anomalous results, such as competition curves that could be either bell-shaped, monophasic or biphasic depending on the assay conditions. The consideration of a radioligand-competitor allosteric interaction allows fitting these curve patterns both under simulation conditions and in real radioligand binding experiments, obtaining competitor affinity parameters closer to the actual values. Our approach is the first that, assuming the formation of receptor homodimers, is able to explain several experimental results previously considered erroneous due to their impossibility to be fitted. We also deduce the radioligand concentration responsible for the conversion of biphasic to monophasic or to bell-shaped curves in competitive radioligand binding assays. In conclusion, bell-shaped curves in competitive binding experiments constitute evidence for GPCR homodimerization.
Introduction
G protein-coupled receptors (GPCRs) comprise the largest protein superfamily in mammalian genomes, covering around 3% of the human proteome [1] . They are involved in 80% or more of the signal transduction processes that occur across cell membranes, exerting their intracellular effects in response to a wide array of extracellular ligands, including single photons, neurotransmitters, hormones and peptides [2] .Their critical role in the mediation of transmembrane signal transduction makes GPCRs therapeutic targets in a large number of diseases, either due to their direct role in the pathophysiology of specific disease or due to their ability to modulate a set of signaling cascades implicated in a specific disease [1, 3] . Therefore, GPCRs are the most important class of membrane proteins in clinical medicine, accounting for about 40% of all current marketed drugs. Moreover, 20% of recently Food and Drug Administration (FDA) approved drugs act through modulating GPCR functions [4] [5] [6] , providing treatments for CNS disorders, cardiac dysfunction, cancer, diabetes, obesity, inflammation, and pain [7] .
The long perceived notion that GPCRs only function in monomeric form [8] [9] [10] [11] [12] [13] has been changed in the last decades by the description of a number of GPCRs of classes A, B and C that are found as homodimers, heterodimers and higher order oligomers (for review, see [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] ). In many cases, oligomeric structures of GPCRs are essential for receptor maturation, ligand pharmacology, signal transduction, and cellular trafficking [22, [27] [28] [29] [30] [31] . Recently, several pharmacological tools have been developed to detect homodimers in vitro, ex vivo and in vivo such as bivalent and bitopic ligands. Interestingly, the bitopic ligand SB269652 was described as the first allosteric molecule able to distinguish between dopamine D 2 receptor (D 2 R) monomers and homodimers [32, 33] . It has also been recently reported a true bivalent ligand that is able to bind simultaneously to both orthosteric sites of the D 2 R homodimer [34] . On the other hand, based on single molecule tracking assays, some authors have reported that GPCR dimerization is a dynamic process in which GPCRs can associate, dissociate and re-associate and that agonists, bitopic and bivalent ligands can alter this dynamics, stabilizing preexisting dimers prolonging their lifetime [35] [36] [37] [38] [39] [40] . However, an equilibrium clearly displaced towards the formation of oligomeric complexes has been proposed for the adenosine A 2A receptor-D 2 R heterotetramer [41, 42] , which forms functional pre-coupled complexes with their cognate Gs and Gi proteins and with subtype 5 of the adenylyl cyclase [43] .
Radioligand binding is widely used to characterize receptors and determine their anatomical distribution. Saturation, competition and kinetic assays are the three types of experiments more commonly used. In saturation experiments, tissue sections, cultured cells, or homogenates are incubated with an increasing concentration of a radioligand, which is usually a radiolabeled synthetic drug. The subsequent analysis using nonlinear regression programs measures the affinity of the labeled ligand for the receptor (equilibrium dissociation constant K D ), and the receptor density (B max ). In kinetic experiments, samples are incubated with a constant radioligand concentration and, measuring its binding along the time, the rate of association (k + or k on ) to or dissociation (k-or k off ) from a receptor is calculated. However, in pharmacological studies, competition binding assays are the most widely used to determine the affinity and selectivity of an unlabeled ligand to compete for the binding of a fixed concentration of radiolabeled ligand to a receptor. Quantitative autoradiography and positron emission tomography (PET) image analysis are other sensitive techniques to detect low levels of radiolabeled ligands and to determine the anatomical distribution of receptors in tissue slices or in whole organs [44] .
Monomeric GPCRs have a single binding site and drug-receptor interactions are driven by the law of mass action, where a drug bounds to a particular receptor at a rate that depends on the concentration of both the drug and the receptor [45] . Therefore, at equilibrium, in saturation-binding studies, the B max expressed by the sample must be the same for all radioligands and should be independent of assay conditions. In competitive binding assays, all ligands should fully compete with each other, and dissociation constants determined in saturation and competition studies must be the same [45] . In this context of monomeric receptors, complex saturation or competition curves are interpreted considering two independent receptor populations that are not in equilibrium: one bound to G protein and the other not. In this scenario, the receptors coupled to G proteins have higher affinity (K DH ) for the agonist. These receptors could then be converted into low affinity (K DL ) receptors with the addition of GTP, which uncouple the G protein from the receptor [46] .
However, given that GPCRs are oligomers, it would be expected that this could alter the properties of the receptor, with equilibrium and kinetic binding assays exhibiting cooperativity [47] . In fact, there is a growing list of receptors that have been found to form homomers, such as adenosine A 1 [48, 49] , A 2A [42, 43, [49] [50] [51] and A 3 [52] , dopamine D 1 [53, 54] , D 2 [41] [42] [43] 55, 56] and D 3 [54, 56] , serotonin 5HT 1A [50] , 5HT 2A [53] , 5HT 2C [57] [58] [59] and 5HT 7 [60] , adrenergic α 1B [53] , β 1 [61, 62] and β 2 [53, 61, 63, 64] , cannabinoid CB 1 [65] , angiotensin AT 1 [66] , metabotropic glutamate mGlu 2 [67] , muscarinic M 1 [53, 68] , M 2 [53, 68, 69] and M 3 [68, 70] , δ [71] [72] [73] , κ [74] and μ [75] opioid, neurotensin 1 [76] , melatonin MT 2 [77] , niacin [78] , and chemokine CXCR4 [79] receptors. Analysis of complex radioligand binding curves, such as upward concave nonlinear Scatchard plots in saturation experiments and as biphasic curves in agonist-antagonist competitive experiments, have contributed to this notion. To deal with receptor homodimers, dimeric models have been developed [80] [81] [82] [83] [84] [85] . These models consider an allosteric communication through the two protomers that allows negative cooperativity, meaning that the binding of a ligand to the first protomer decreases the affinity of the same ligand for the second protomer. In these cases, when handling with complex radioligand-binding curves, the use of the traditional two-independentsite model generates values for the equilibrium dissociation constants and for the number of receptors that vary significantly depending on the concentration of the radioligand employed [86, 87] . This lack of robustness of the two-independent-site model indicates that it is inappropriate and that the parameters must be estimated using a dimer receptor model [24, 25] . In other cases, when working with dimeric receptors and using monomeric models, dissociation constants determined in saturation and competition experiments do not match [47, 88] . Moreover, concave-downward Scatchard plots, i.e. positive cooperativity [88] , only can be explained by dimeric models. In addition, mismatches in constant values obtained when dissociation is performed by dilution vs. by an excess of unlabeled ligand [48, [89] [90] [91] cannot be explained by monomeric receptor models either. Here, we focus on anomalous competitive binding experiments, when curves appear as biphasic, monophasic or bell-shaped depending on the assay conditions. Previously, Wreggett and Wells [92] , working with cardiac muscarinic receptors, reported that non-hydrolysable guanyl nucleotides induced bell-shaped curves in competitive radioligand binding assays which would only be interpretable assuming tetrameric receptors and a modulation between agonist and radioligand. Albizu et al. [88] also showed some competition curves exhibiting an increase of the radioligand binding to vasopressin receptors for low concentrations of competitors, suggesting a cooperative binding process. Later, we provided experimental evidence showing the effect of radioligand concentration on the conversion of biphasic to monophasic curves [93] . Now, we demonstrate that the existence of a radioligandcompetitor allosteric interaction deduced from our dimer receptor model allows the fitting of bell-shaped curves, typically considered as anomalous or erroneous results. We also deduce the radioligand concentration responsible for the conversion of biphasic to monophasic or to bell-shaped curves in competitive radioligand binding assays. These curves are only interpretable assuming the formation of receptor homodimers.
Materials and methods

Membrane preparation and protein determination
Membrane suspensions from sheep brain striatum were processed as described previously [94, 95] . Tissue was disrupted with a Polytron homogenizer (PTA 20 TS rotor, setting 3; Kinematica, Basel, Switzerland) for three 5 s-periods in 10 volumes of 50 mM Tris−HCl buffer, pH 7.4 containing a protease inhibitor cocktail (1:1000, Sigma, St. Louis, MO, USA). Cell debris were eliminated and membranes were obtained by centrifugation at 105,000 x g (60 min, 4°C), and the pellet was resuspended and recentrifuged under the same conditions. The resulting V. Casadó-Anguera et al. Pharmacological Research 139 (2019) [337] [338] [339] [340] [341] [342] [343] [344] [345] [346] [347] pellet was stored at -80°C and washed once more as described above and resuspended in 50 mM Tris−HCl buffer for immediate use. Protein was quantified by the bicinchoninic acid method (Pierce Chemical Co., Rockford, IL, USA) using bovine serum albumin dilutions as standard.
Radioligand binding experiments
For radioligand competition experiments, membrane suspensions (0.2 mg protein/ml) were incubated 2 h in 50 mM Tris−HCl buffer, pH 7.4, containing 10 mM MgCl 2 and 0.2 U/ml (1 μg/ml) desalted bovine adenosine deaminase (EC 3.5. Nonspecific binding was determined in the presence of an excess of the corresponding unlabeled antagonist and confirmed that the value was the same as calculated by extrapolation of the competition curves. Free and membrane bound radioligands were separated by rapid filtration of 500 μl aliquots (for the competition assays) or 10 ml (for the dissociation assays) in a cell harvester (Brandel, Gaithersburg, MD, USA) through Whatman GF/C filters embedded in 0.3% polyethylenimine that were subsequently washed for 5 s with 5 ml of icecold Tris−HCl buffer. The filters were incubated with 10 ml of Ultima Gold MV scintillation cocktail (PerkinElmer, Boston, MA, USA) overnight at room temperature and radioactivity counts were determined using a Tri-Carb 2800 scintillation counter (PerkinElmer, Boston, MA, USA) with an efficiency of 62% [95] .
Binding data analysis using the dimer receptor model
Radioligand saturation curves were analyzed by nonlinear regression using the commercial Grafit curve-fitting software (Erithacus Software, Surrey, UK), by fitting the specific binding data to our dimer receptor model [25, 83, 93] . To calculate the macroscopic equilibrium dissociation constants involved in the binding of the radioligand, the following equation deduced by Casadó et al. [83] was considered:
where A represents the free radioligand (the A 1 R antagonist
SCH23390) concentration, R T is the total amount of receptor dimers and K DA1 and K DA2 are the macroscopic dissociation constants describing the binding of the first and the second radioligand molecule (A) to the receptor homodimer.
Radioligand competition curves were also analyzed by nonlinear regression fitting experimental data to the following equation deduced from our dimer receptor model [83] :
where A represents the radioligand (the A 1 R antagonist [
concentration, R T is the total amount of receptor dimers and K DA1 and K DA2 are the macroscopic dissociation constants describing the binding of the first and the second radioligand molecule (A) to the dimeric receptor; B represents the assayed competing compound (the A 1 R agonist R-PIA, the A 2A R antagonist SCH442416, or the D 1 R agonist SKF81297) concentration and K DB1 and K DB2 are, respectively, the equilibrium dissociation constants of the first and second binding of B; K DAB can be described as a hybrid equilibrium radioligand-competitor dissociation constant, which is the dissociation constant of B binding to a receptor dimer semi-occupied by A.
Since the radioligand A (the antagonist [ (2) was simplified to Eq. (3) due to the fact that K DA2 = 4K DA1 (see [83] ):
The dimer cooperativity index for the radioligand A or the competing ligand B was calculated as (see [83] ):
where 0 means non-cooperative value, positive values indicate positive cooperativity, whereas negative values imply negative cooperativity. In the experimental conditions when both the radioligand A and the competitor B show non-cooperativity, it results that K DA2 = 4K DA1 and K DB2 = 4K DB1 , and Eqs. (2) and (3) were simplified to:
The radioligand-competitor allosteric index can be calculated according to the equation:
where 0 means that the presence of the radioligand does not affect the binding of the competitor to the empty protomer within the dimer, and vice-versa. Positive or negative values of D AB indicate that the presence of the radioligand increases or decreases, respectively, the affinity of the competitor for binding to the empty protomer within the dimer. D AB and D BA are correlated because K DBA = K DAB K DA1 /K DB1 [48] . For comparison, data were also fitted to the classical one-site receptor model when monophasic competition curves were observed and to the classical two-independent-site receptor model when biphasic competition curves were obtained, using respectively the equations: 
Dissociation kinetic data were fitted to the following empirical equation:
where A ei represents the initial radioligand (the D 1 R antagonist [ 3 H] SCH23390) specifically bound at equilibrium for each molecular specie i, t is time and k i is the dissociation rate constants for the n different molecular species. For monophasic curves n = 1, and for biphasic curves n = 2. Goodness of fit was tested according to reduced χ 2 value given by the nonlinear regression program. The test of significance for two different model population variances was based upon the F distribution (see [94] , for details). Using this F test, a probability greater than 95% (p < 0.05) was considered the criterion to select a more complex model (cooperativity in Eq. (3) or two-sites in Eq. (8)) over the simplest one (non-cooperativity in Eq. (5) or one site in Eq. (7)). Results are given as parameter values ± SEM of three independent experiments performed with different striatum homogenates of 3-4 animals.
Results
Adenosine A 1 receptors show slightly bell-shaped competitive curves
Working with A 1 R, competition experiments are usually performed with an antagonist radioligand, such as [ Table 1 and the fitting curve is represented in Fig. 1A . The affinity values of R-PIA deduced from Cheng and Prusoff equation (Eq. 9) [96] are much higher than those obtained from saturation assays that were in the low nM range [48] . As we can see, the points showing enhanced radioligand binding are left out. However, if we use our dimer receptor model (see Methods), and the points showing enhanced radioligand binding have low experimental dispersion, the bell-shaped curve can be accurately fitted by Eq. (3) using K DA1 = 0.038 nM [48] (see Fig. 1B ). The parameter values obtained also appear in Table 1 . Our dimer receptor model is able to explain the enhanced radioligand binding at low displacer concentrations due to the existence of an allosteric interaction between the two orthosteric ligands, radioligand ([ 3 H]DPCPX) and competitive displacer (R-PIA), which is measured by the K DAB parameter (see Methods and Table 1 ).
By including this parameter in the fit, the two affinity values obtained for cooperative R-PIA are closer to the expected values from saturation assays [48] . However, if the points showing enhanced radioligand binding have high experimental dispersion, the inclusion of a new parameter (K DAB ) does not significantly improve data fit to the dimer receptor model. In this case, the points showing enhanced radioligand binding are commonly underestimated and the fit to the dimer model overlaps with that obtained using the two-independent-site model.
Adenosine A 2A receptors show moderate bell-shaped competitive curves
Next, we moved to competitive radioligand binding assays with the A 2A R due to our expertise with the displacement of the A 2A R agonist [ Table 1 . or (8)), the first points are not correctly fitted, and the points showing enhanced radioligand binding are left out (Fig. 2A, dashed line) . When fitting binding data to our dimer receptor model, we can consider the competitor SCH442416 as non-cooperative and only use the K DB1 parameter (Eq. (5) with K DAB = 2K DB1 ). The values obtained, using K DA1 = 41 nM [51] , appear in Table 2 and the regression curve (solid line) roughly overlaps with the dashed line in Fig. 2A . In contrast, if we consider that the antagonist shows cooperativity, we must include a second parameter, K DB2 (Eq. (3) with K DAB = 2K DB1 ). In this case, the fit is not better and overlaps with the solid line. Only when we consider the presence of an allosteric modulation between radioligand and competitor (K DAB parameter), we obtain a bell-shaped curve and all points are correctly fitted (Eq. (5)) (see Fig. 2B ). All parameter values obtained also appear in Table 2 . Importantly, only the high affinity value obtained for SCH442416 (K DB1 ) by fitting the bell-shaped curve with K DAB is according with the high affinity value reported for this antagonist [97, 98] , and this K DB1 value is significantly lower (p < 0.05) than the obtained without K DAB (see Table 2 ). Moreover, the fit with the dimer receptor model including the K DAB parameter is statistically better (p < 0.05) than the fit not including the K DAB (Fig. 2) . These results again show that the radioligand-competitor allosteric interaction measured by K DAB is responsible for obtaining bellshaped curves in competitive binding assays.
Dopamine D 1 receptors clearly show bell-shaped competitive curves
Then, we wanted to test our model with competitive curves working with D 1 R because we previously reported the existence of a great radioligand-competitor allosteric interaction between [ 3 H]SCH23390 and the agonist SKF81297 and because of the low experimental dispersion when working with this radioligand. The K DAB value was 2 ± 1 nM, two times lower than the K DB1 value (7 ± 1nM), pointing out a positive effect of 3) ), the fit was statistically not better (see Methods). In Fig. 3C we show a magnification of a representative bell-shaped curve obtained at low radioligand concentration, also fitted to monomeric models (dotted line) according to Eq. (7). The fit to the dimer model was significantly better than to the monomeric model (p < 0.05). The parameter values obtained with Eq. (5) appear in Table 3 .
Simulating biphasic, monophasic and bell-shaped competitive binding curves with the dimer receptor model
Previously, we reported that competition experiments between [ 3 H] SCH23390 and SKF81297 showed biphasic curves even in the absence of any cooperativity of the radioligand or the competitor [93] . Assuming a marked positive radioligand-competitor modulation (D AB > > 0), our dimer receptor model predicted the evolution from biphasic to monophasic patterns when decreasing the radioligand concentration in the assay [93] . Now, we simulate a set of competition curves considering the general competitive Eq. (5) Table 2 . Values are mean ± SEM from three experiments performed with different striatum membranes of 3-4 animals. The radioligand affinity was K DA1 = 41 nM. B max is the maximum specific binding and K D is the equilibrium dissociation constant for the competing ligand B (SCH442416). R T is the total amount of receptor dimers, K DB1 and K DB2 are, respectively, the equilibrium dissociation constants of the first and second binding of B to the dimer. K DAB is the hybrid equilibrium dissociation constant of B binding to a receptor dimer semioccupied by A ([ vs. increasing concentrations of SKF81297 fitted to the dimer receptor model (Eq. (5)) (solid line) or fitted to the one-site model (Eq. (7)) (dotted line). Mean ± SEM values from a representative experiment performed in triplicates are shown. Parameter values appear in Table 3 . (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) Values are mean ± SEM from three experiments performed with different striatum membranes of 3-4 animals. The radioligand affinity was K DA1 = 0.27 nM. B max is the maximum specific binding and K D is the equilibrium dissociation constant for the competing ligand B (SKF81297). B maxH and B maxL are, respectively, the maximum specific binding corresponding to, respectively, high-and low-affinity sites, and K DH and K DL are the equilibrium dissociation constants of the competing ligand B for, respectively, high-and low-affinity sites. R T is the total amount of receptor dimers, K DB1 and K DB2 are, respectively, the equilibrium dissociation constants of the first and second binding of B to the dimer. K DAB is the hybrid equilibrium dissociation constant of B binding to a receptor dimer semioccupied by the A ( (Fig. 4B) is Eq. (5) (see Methods). Then, for any two curves n and m of this figure, the radioligand bound is:
where all parameters are the same except for K DABn and K DABm (in bold in the equations). At the B concentration of the competitor corresponding to the singular pinched point, all curves have the same radioligand bound and, then, A bound n = A bound m . Therefore, equaling the two expressions and solving the system, we obtain the quadratic Eq.
:
Only one solution is possible (positive):
but just if A > 2K DA1 . In any other case, the concentration of B would be negative i.e. unreal. The B concentration at the pinched point considering the simulated parameter values is 30 nM, with A bound =R T , i.e. with the dimers semi-occupied, exactly as deduced from Fig. 4B .
Which graph pattern is obtained when A = 2K DA1 ? To answer this question, we simulated this scenario in Fig. 4D , obtaining only monophasic curves. Thus, for the parameters employed in the simulations of the Fig. 4 , the critical concentration of the radioligand is A = 2 nM.
The last question is: what radioligand concentration (A) is responsible for obtaining bell-shaped curves? The answer to this question can be found determining the slope of the curve corresponding to Eq. (5). The derivative of A bound with respect to competitor concentration (B), when B tends to zero, must be positive to observe a bell-shaped curve, and its value must be negative for obtaining decreasing monophasic curves. When the derivative is zero, we obtain the quadratic expression (Eq. (13)):
Solving the Eq. (13), we find the maximum critical A concentration that allows the obtaining of a bell-shaped curve:
It is easily deduced that A must be lower than 2K DA1 and that it tends to 2K DA1 value when K DAB is much lower than K DB1 (high positive radioligand-competitor allosteric interaction). In addition, K DB1 must be higher than K DAB . We can also deduce the competitor B corresponding to the maximum of the bell-shaped curve (equation not shown), being always B ≤ 2K DB1 -2K DAB and tending to 2K DB1 -2K DAB for low radioligand concentrations (A tending to 0).
In conclusion, if A and B are non-cooperative and there is a positive radioligand-competitor interaction (positive D AB ), when using radioligand concentrations higher than 2K DA1 , the curves will be biphasic in competition experiments (Fig. 4B) . In contrast, when A = 2K DA1 , monophasic curves are always obtained (Fig. 4D) . Finally, when A < 2K DA1 , we can obtain bell-shaped curves if K DAB < K DB1 and A specifically lower than 2K DA1 (K DB1 -K DAB )/K DB1 (Fig. 4C) or, in any other cases, curves will be always monophasic.
Bell-shaped competitive curves with dopamine D 1 receptors can be modulated according with the radioligand concentration used
We proved the hypothesis deduced above from our dimer receptor model, i.e. that competitive curve patterns experimentally vary (5)).
V. Casadó-Anguera et al. Pharmacological Research 139 (2019) [337] [338] [339] [340] [341] [342] [343] [344] [345] [346] [347] depending on the radioligand concentration employed in the assays and the different data sets can be properly fitted with our model. Effectively, the bell-shaped curve (Fig. 3B , blue line) was obtained at a low free radioligand concentration of 0.15 nM, lower than 2K DA1 = 0.54 nM. Under these conditions the above simulation predicts that the existence of a radioligand-competitor interaction (K DAB = 2.5 nM) can generate bell-shaped competition curves. The same experiment showed a biphasic pattern (Fig. 3B, red (3) were now monophasic, as showed in Fig. 3B (black line) . These results experimentally demonstrate that the pattern of the competitive curves can vary according to the radioligand concentration employed, due to the existence of a positive radioligand-competitor interaction (D AB > 0) in a receptor homodimer and, for the first time, this fact is taken into account by our dimer receptor model with the inclusion of the K DAB parameter. The affinity values of SKF81297 are highly robust at the three concentrations of radioligand used (from 3 to 9 nM, not significantly different), and are in the range of previously reported values [93] . Moreover, it should be noted that not only the affinity values, but also the number of receptors deduced using the dimer receptor model including the K DAB parameter (Eq. 5) are robust (from 0.39 to 0.44 pmol/mg protein, not significantly different) and do not depend on the concentration of the radioligand employed (see Table 3 ). Conversely, both the affinity and the number of receptors obtained by the monomeric one-site (Eq. (7)) or two-site (Eq. (8)) model considerably vary depending on the radioligand concentration ( ) and the agonist (SKF81297) represented by the K DAB parameter, which accounts for the bell-shaped curves in Fig. 3B -C. We also show in Table 4 the dissociation kinetic parameters obtained with A 2A Rs and previously reported by us [41, 42] , which also demonstrated A 2A R homodimerization and the existence of an allosteric interaction between radioligand and competitor (agonist vs. antagonist) represented by the high value of D AB (+1.9); this parameter is shown in Table 2 and is responsible for the marked bell-shaped curve of Fig. 2B. 
Discussion
When analyzing competitive binding experiments, we sometimes obtain the surprising findings of a biphasic curve using an antagonist ligand or a monophasic curve using an agonist ligand, as competitors. Even more anomalous are those curves showing a bell-shaped pattern, where increasing concentrations of a competitor produce an increase of the radioligand binding before causing the expected displacement. This increase is usually from low to moderate; for example, when working with vasopressin receptors, increases in radioligand binding were frequently observed which did not exceed 20% of the binding in the absence of competitor [88, 99] . Now, we demonstrate that the existence of a radioligand-competitor allosteric interaction (K DAB ), deduced from our dimer receptor model [93] (see Fig. 5 ), allows the fitting of bellshaped curves, typically considered as anomalous or erroneous results. We also deduce the radioligand concentration responsible for the conversion from biphasic to monophasic or to bell-shaped curves in competitive radioligand binding assays. Moreover, according to the K DAB definition, these bell-shaped curves are only interpretable assuming the formation of receptor homodimers and, therefore, obtaining bellshaped curves in competition experiments is a clear evidence for receptor dimerization ex-vivo, working with membrane preparations from tissues. These results are according with those obtained by radioligand dissociation kinetic assays. It is well established the use of this method to detect cooperative interactions between two distinct binding sites and thus, to determine the presence of homodimers and heteromers [100] . Concretely, with this method it was demonstrated the presence of homodimers of A 2A R ex vivo in sheep striatum membranes [42] and of A 1 R in CHO transfected cells [52] . Here, by dissociation kinetic experiments, we have also demonstrated the presence of D 1 R homodimers in striatal membranes, which is according with the detection of a K DAB parameter indicating homodimerization in the competitive binding assays now reported.
In agreement with our results, we can decrease the radioligand concentration under its affinity value (2K DA1 or lower) to obtain bellshaped competition curves. This is a demonstration of the existence of positive radioligand-competitor interaction (D AB > 0), denoted by a low K DAB value. In this scenario, if K DAB < K DB1 , we will obtain bellshaped curves but, if K DAB is between K DB1 and 2K DB1 , we will obtain monophasic curves. Working with high affinity radioligands, radioligand concentration much higher than their K DA1 values are usually used, which precludes the observation of bell-shaped curves. In addition, if the value of D AB is low, in order to observe the bell-shaped curves, the radioligand concentration should be significantly reduced. Otherwise, the bound ligand would be low and the experimental dispersion could mask the bell-shaped pattern of the competitive curves, as showed in Fig. 1 . The use of radioligand concentrations under their 2K DA1 values is more common when working with low affinity radioligands. In these cases, competition experiments similar to those It is interesting to note that, although there is clear evidence of the dimerization of GPCRs, currently, radioligand binding data are still fitted to equations deduced for one site or for two-independent site models. This is because experimental data usually fit equally to these simpler models or to the dimer receptor model. The experiments showed here, i.e. bell-shaped curves in competition assays, only can be explained considering homodimeric/oligomeric receptors and fitting data to a dimer receptor model. Chidiac et al. [80] also suggested that a bell-shaped pattern cannot be obtained from a system of independent sites. Likewise, the conversion of the curve pattern from biphasic to monophasic [93] and to bell-shaped curves, decreasing the radioligand concentration in the competition assay, only can be interpreted by dimeric or oligomeric models. Our model explains all these cases due to the existence of a radioligand-competitor allosteric interaction, only explainable if receptors form homodimers. Our dimer receptor model can overcome scenarios where different affinity values for a competitive drug are obtained, when different radioligands are used and monomeric models are applied [45] . This is because our model takes in account that each pair of radioligand-competitor has a particular K DAB value according to the magnitude of its allosteric interaction. If this K DAB value is not included in the mathematical fitting model, the affinity values of the competitor obtained with the monomeric one-site and two-independent-site models will not be robust, but inconsistent and erroneous. Furthermore, when bell-shaped curves are obtained in competitive radioligand binding assays, the affinity values of the competitor obtained from equations including K DAB are closer to the actual values. On the contrary, the K D values obtained from classical monomeric models are usually much higher.
Conclusion
In summary, by assuming the formation of receptor homodimers, our study is the first that can explain several experimental results previously considered erroneous due to their impossibility to be well fitted. Furthermore, our model is easy to use, in contrast to the overparameterization of other dimer receptor models, and it can successfully predict the pattern of competition curves according to the experimental conditions. Our findings have potential therapeutic interest because GPCR homodimers are the actual and better target for drug development, and the agonist-antagonist allosteric interaction within GPCRs must be taken into account when designing new therapeutic strategies. V. Casadó-Anguera et al. Pharmacological Research 139 (2019) [337] [338] [339] [340] [341] [342] [343] [344] [345] [346] [347] 
